Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ahad Abushal
Fingolimod (FTY720) as an Anti-Multiple Sclerosis Oral Ultimate Therapy
Biosciences Biotechnology Research Asia
Biotechnology
Agronomy
Crop Science
Drug Discovery
Related publications
FTY720 (Fingolimod) Efficacy in an Animal Model of Multiple Sclerosis Requires Astrocyte Sphingosine 1-Phosphate Receptor 1 (S1P1) Modulation
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Myeloid Cells as Target of Fingolimod Action in Multiple Sclerosis
Neurology: Neuroimmunology and NeuroInflammation
Neurology
Tumefactive Multiple Sclerosis Lesions Under Fingolimod Treatment
Neurology
Neurology
Debate on the Treatment of Multiple Sclerosis: Experience From an Intractable Multiple Sclerosis Case With Rebound Syndrome After Fingolimod Cessation
Clinical and Experimental Neuroimmunology
Neuroscience
Neurology
Immunology
Microbiology
Natalizumab Versus Fingolimod and Dimethyl Fumarate in Multiple Sclerosis Treatment
Annals of Clinical and Translational Neurology
Neuroscience
Neurology
Extensive Multiple Sclerosis Reactivation After Switching From Fingolimod to Rituximab
Case Reports in Neurological Medicine
Fingolimod (FTY720) Stimulates Ca2+/Calcineurin Signaling in Fission Yeast
PLoS ONE
Multidisciplinary
Predictors for Multiple Sclerosis Relapses After Switching From Natalizumab to Fingolimod
Multiple Sclerosis
Neurology
Severe CD4 Lymphocytopenia in Patients With Multiple Sclerosis Treated With Fingolimod
Journal of Allergy and Clinical Immunology
Allergy
Immunology
